港股異動 | 10月合同銷售額大增 建業地產續漲逾4%
格隆匯11月7日丨建業地產(0832.HK)繼前面三個交易日連續上漲後,於今日至現價4.2港元再度上漲4.48%,四連升累計上漲19%,暫成交1394.7萬港元,最新總市值114.8億港元。公司昨日公告稱,2019年10月份集團取得物業合同銷售額人民幣86.30億元,同比增加為85.2%。交銀國際研報指,公司目前充裕的低成本土儲足以應付四年的開發,即使不再購地,亦有望於明年躋身千億銷售房企,預計公司將吸引更多投資者關注,從而釋放隱藏價值,目前估值相對小型內房股較便宜,首予“買入”投資評級,目標價6.1港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.